PHARMALEX GMBH -  

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 12.778.595 943.750 1
2019 0 14.959.781 676.381 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
AEROGEN1
AOFORSCHUNGSINSTITUT DAVOS1
CATALYZE BV1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
EINDHOVEN UNIVERSITY OF TECHNOLOGY1
EVERZOM1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
MYRIAD CONSULTING LIMITED1
NATIONAL UNIVERSITY OF IRELAND GALWAY1
NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN1
NTRANS TECHNOLOGIES BV1
OMNISPIRANT LIMITED1
REMEDY BIOLOGICS LIMITED1
SHEFFIELD HALLAM UNIVERSITY1
SPINESERV GMBH & COKG1
STICHTING REUMANEDERLAND1
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN1
THE UNIVERSITY OF HONG KONG1
UNIVERSITA CAMPUS BIO MEDICO DI ROMA1
UNIVERSITAET BERN1
UNIVERSITAET ULM1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITE DE MONTPELLIER1
UNIVERSITE DE NANTES1
UNIVERSITEIT UTRECHT1
UNIVERSITY OF MIAMI1

Constancy:

Total number of partners: 27
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 27
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-06-01Developing novel inhaled bioengineered Extracellular Vesicle RNA based advanced therapeutics, delivered by tailored aerosol delivery technology for the treatment of lung cancer INSPIREparticipant12.778.5958
2019-01-01Induced pluripotent stem cell-based therapy for spinal regeneration iPSpineparticipant14.959.78121